(Q47994071)

7 February 2018

title

Intravitreal bevacizumab as an adjunct in a patient with presumed vascularised choroidal tubercular granuloma. (English)

1 reference

7 February 2018

1 reference

K Babu

1

1 reference

7 February 2018

P R Murthy

series ordinal

2

1 reference

7 February 2018

K R Murthy

series ordinal

3

1 reference

7 February 2018

publication date

17 April 2009

1 reference

7 February 2018

published in

Eye

1 reference

7 February 2018

volume

24

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

397-399

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/eye.2009.83

exact match

0 references

cites work

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.83

7 January 2021

Ocular tuberculosis masquerading as ocular tumors

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.83

7 January 2021

Photodynamic therapy as an adjunct to systemic treatment in a case with unilateral presumed vascularized choroidal tuberculous granuloma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.83

7 January 2021

[Vasoproliferative tumor associated with presumed ocular tuberculosis: case report]

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.83

7 January 2021

Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.83

7 January 2021

Identifiers

DOI

10.1038/EYE.2009.83

1 reference

7 February 2018

PubMed ID

19373263

1 reference

7 February 2018